FDA Approval of New Alzheimer’s Drug May Boost Prospects of Other Treatments
The FDA’s reasoning for greenlighting Biogen’s Aduhelm could bode well for other Alzheimer’s drugs targeting the disease in a similar way.
Full Article
FDA Approval of New Alzheimer’s Drug May Boost Prospects of Other Treatments
Upworthy
0 shares
1 views
You might like
Related news coverage
Lilly to seek FDA approval for potential Alzheimer's drug
SeattlePI.com
INDIANAPOLIS (AP) — Eli Lilly is nearly ready to take another shot at getting approval for a possible Alzheimer's..
-
NA Proactive news snapshot: Progressive Planet, Real Luck Group, Deep-South Resources, Kidoz, Sigma Lithium UPDATE …
Proactive Investors
-
NA Proactive news snapshot: Sigma Lithium Resources, Progressive Planet Solutions, NEO Battery Materials, Victory Square Technologies UPDATE …
Proactive Investors
-
FDA officials should resign over 'reckless' approval of Biogen Alzheimer’s drug, says US consumer rights group
Proactive Investors
-
First patient set to receive controversial Biogen Alzheimer' s drug
MENAFN.com
Advertisement
More coverage
FDA Approves Highly Debated Alzheimer’s Drug
Newsy
Watch VideoGovernment health officials on Monday approved the first new drug for Alzheimer's disease in nearly 20 years,..
Campbell Soup, Comtech fall; Merck, Vertex rise
SeattlePI.com